Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer.

BMC Cancer · 2014 · PMC4289341 · PMID 25428203

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

showed a trendp = 0.065so close (0.05 < p ≤ 0.1)

Increasing APOE serum levels showed a trend for shorter PFS (HR 1.17, 95% CI 0.99-1.37, p = 0.065) and OS (HR 1.17, 95% CI 0.99-1.39, p = 0.060).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.